Document is current
Any future updates will be listed below
-
Authors
Drobek, Ales https://orcid.org/0000-0003-1066-9413
Bernaleau, Léa https://orcid.org/0009-0006-5892-0151
Delacrétaz, Maeva https://orcid.org/0009-0003-4154-5277
Calderon Copete, Sandra
Royer-Chardon, Claire
Longepierre, Mélissa
Monguió-Tortajada, Marta https://orcid.org/0000-0003-2125-0810
Korzeniowski, Jakub https://orcid.org/0009-0005-1344-7084
Rotman, Samuel https://orcid.org/0000-0002-2508-3725
Marquis, Julien https://orcid.org/0000-0002-2020-1534
Rebsamen, Manuele https://orcid.org/0000-0001-6172-4211
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_200709)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_200709)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_200709)
- License Information
-
More Information
Article History
Received: 5 January 2024
Accepted: 14 November 2024
First Online: 24 January 2025
Competing interests
: M.R. is an advisor of Solgate GmbH, Austria, and an inventor on European priority patent applications (EP 22 203 423.3, EP 22 203 422.5, EP 22 203 421.7, status: filed) covering small-molecule modulators of TASL and their medical use. The other authors declare no competing interests.
